Compare SNTI & JVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SNTI | JVA |
|---|---|---|
| Founded | 2016 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.8M | 17.8M |
| IPO Year | 2021 | 1997 |
| Metric | SNTI | JVA |
|---|---|---|
| Price | $0.95 | $4.30 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $8.50 | N/A |
| AVG Volume (30 Days) | ★ 181.8K | 39.6K |
| Earning Date | 05-06-2026 | 06-12-2026 |
| Dividend Yield | N/A | ★ 1.71% |
| EPS Growth | ★ 77.31 | N/A |
| EPS | N/A | ★ 0.29 |
| Revenue | N/A | ★ $90,655,294.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $15.24 |
| Revenue Growth | N/A | ★ 17.54 |
| 52 Week Low | $0.77 | $2.93 |
| 52 Week High | $3.88 | $5.62 |
| Indicator | SNTI | JVA |
|---|---|---|
| Relative Strength Index (RSI) | 47.55 | 47.13 |
| Support Level | $0.86 | $4.13 |
| Resistance Level | $1.02 | $4.79 |
| Average True Range (ATR) | 0.07 | 0.16 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 40.88 | 33.06 |
Senti Biosciences Holdings Inc, formerly known as Senti Biosciences Inc, is a clinical-stage biotechnology company developing cell and gene therapies using its gene circuit platform for patients with incurable diseases. Its gene circuits, created from proprietary DNA sequences, are designed to reprogram cells to sense, compute, and respond to cellular environments. Its product candidates are to kill cancer cells, spare healthy cells, increase specificity, and control drug expression. Its candidate, SENTI-202, is a logic-gated off-the-shelf CAR-NK cell therapy for blood cancers, currently in a Phase 1 clinical trial in the United States and Australia for relapsed or refractory hematological malignancies, including Acute Myeloid Leukemia (AML).
Coffee Holding Co Inc is engaged in wholesale coffee operations, including manufacturing, roasting, packaging, marketing, and distributing roasted and blended coffees for privately labeled accounts and its brands, and it sells green coffee. The Company also manufactures and sells coffee roasters. Its products include wholesale green coffee, private-label coffee, and branded coffee. The company sells its coffee products throughout the United States, Canada, and certain Asian countries. The group's services are Custom Blending, Food Service Programs, and Private Label Services.